Skip to content

Hyris Technology Supports the Fight Against One of the World’s Deadliest Diseases, Malaria

By API User

Hyris’ molecular diagnostic technology has been adapted to enable real-time surveillance of mosquito vector insecticide resistance, which will aid in malaria control campaigns. LONDON, UK / ACCESSWIRE / February 20, 2024 / Hyris, working with an international team of researchers, has developed a prototype field-deployable surveillance system to detect insecticide-resistant malaria vector mosquitoes in the … Continued

When art collides with science and technology, magic happens: ANAT Synapse 2024 residents announced

By API User

When art collides with science and technology, magic happens   ANAT Synapse 2024 residents announced $20,000 Fellowship unveiled celebrating 20 years of art + science synergy For the past 36 years, the Australian Network for Art & Technology (ANAT) has cultivated opportunities for artists to create experimental work in and with science and technology, playing … Continued

Blood test to detect dementia: expert available for comment

By API User

Professor Matthew Kiernan AM CEO at Neuroscience Research Australia is available to provide expert comment on the development of an early blood test to predict dementia, as reported by the Guardian today based on research published in nature aging.  Professor Kiernan AM is an expert in neurodegenerative diseases, particularly motor neuron disease (MND) and frontotemporal dementia … Continued

New study reveals kill order for melanoma cells by cannabis extract

By API User

A cannabis extract has shown positive results in slowing down melanoma cell growth and increasing cell death rates, a new in-vitro study finds. Researchers from Charles Darwin University (CDU) and RMIT investigated programmed cell death caused by a specific cannabis extract (cannabinoid PHEC-66) from the cannabis sativa plant. The study that was part of a PhD project … Continued

New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine

By API User

Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline glioma in Science Advances. HEIDELBERG, GERMANY / ACCESSWIRE / February 6, 2024 / BioMed X and the Universitätsmedizin Mannheim announced today the publication of two manuscripts in the field of … Continued

Study on the safety of Elixinol Hemp Extract is published in Journal of Toxicology

By API User

Elixinol Wellness Limited (ASX: EXL) continues to be a pioneer in the global hemp industry, with the release of a new paper into the safety of Elixinol Hemp Extract in leading scientific publication, Journal of Toxicology. The paper, entitled “Safety of Elixinol Hemp Extract: In VitroGenetic Toxicity and Subchronic Toxicity in Rat”, reports on safety studies of Elixinol … Continued

Elon Musk’s Neuralink: Dr Steve Kassem available to comment

By API User

Dr Steve Kassem from Neuroscience Research Australia is available to provide his expert comment on Elon Musk’s Neuralink.  Dr Kassem is a brain cartographer and works at NeuRA’s Brain Mapping Facility with Professor George Paxinos AO. He is an experienced media spokesperson, having appeared on radio and television numerous times, as well as being a … Continued

Jane Morgan and Brian Leedman Appointed to the Board of Directors of BlinkLab – Early and Accurate Detection of Autism using an AI-driven Smartphone Platform.

By API User

BlinkLab, the groundbreaking early detection diagnostic tool for Autism and other neurological disorders, is pleased to announce the appointments of Jane Morgan as a Non-Executive Director and Brian Leedman as Chairman of the Board. These significant additions to the board come as BlinkLab prepares for listing on the Australian Securities Exchange (ASX), with Westar Capital … Continued

Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance

By API User

TRONDHEIM, NORWAY / ACCESSWIRE / January 17, 2024 / Chiron AS, a leading producer of chemical reference materials headquartered in Trondheim, Norway, is pleased to announce the establishment of a state-of-the-art research centre dedicated to the enhanced surveillance of environmental pollutants. This ground-breaking development, supported by an estimated 40 million NOK investment, reaffirms Chiron’s commitment … Continued

Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market

By API User

Following the first official announcement at the beginning of December last year, Hyris completed the transfer of its shares into Ulisse Biomed via a reverse take-over transaction. The new group, strong of flawless interoperability between its leading technologies, aims to become a new benchmark of innovation in the national and international biotech market. LONDON, ENGLAND … Continued